Ketoconazole Actavis (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of fungal cell membranes. Inhibiting this pathway weakens the membrane, halting fungal growth and leading to cell death of susceptible organisms.

The dosage and duration of Ketoconazole Actavis are determined by the prescribing healthcare professional based on the specific infection, its severity, and the treated body area. Patients should follow the prescriber’s instructions and the product label for application frequency and length of therapy.

Safety data for topical ketoconazole in pregnancy and lactation are limited. Healthcare providers usually weigh potential benefits against risks before prescribing. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their clinician to determine if an alternative treatment is more appropriate.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ketoconazole belongs to the imidazole class and is effective against a broad range of dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, ketoconazole may have a broader spectrum but can cause more local irritation. Choice of therapy depends on infection type, patient tolerance and clinician preference.

Store Ketoconazole Actavis at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Apply a thin layer of the topical formulation to the affected skin area, usually once or twice daily as directed by the prescriber. Wash hands before and after application, and avoid contact with eyes, mucous membranes and broken skin unless instructed otherwise.

Serious risks, though rare, include severe allergic reactions such as angioedema or anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and significant photosensitivity. If any signs of severe skin reaction, systemic symptoms, or liver dysfunction appear, discontinue use and seek medical attention promptly.

Individuals with a known hypersensitivity to ketoconazole, other imidazole antifungals, or any component of the formulation should avoid use. It is also contraindicated on extensive broken skin, in patients with severe liver disease when systemic absorption is possible, and in those advised against topical antifungals by their clinician.